New Delhi, May 21 -- The Q-Line Biotech initial public offering (IPO) began on Thursday, 21 May, and will end on Monday, 25 May. Q-Line Biotech IPO price band is set at Rs.326 to Rs.343 per equity share, with a face value of Rs.10 per share.

Investors can bid for a minimum of 400 equity shares, with the option to acquire additional shares in increments of 400.

Founded in 2010, Q-Line Biotech is engaged in the creation, production, and marketing of diagnostic reagents, kits, point-of-care (POC) devices, and consumables, as well as the production, importation, and distribution of diagnostic equipment designed to meet various healthcare requirements.

Since 2013, the firm has provided diagnostic equipment and in-vitro diagnostic (IVD) prod...